Emerging Infections and Antimicrobial Resistance

We are currently seeking Senior Research Fellows/ Academic Level C in emerging infections and antimicrobial resistance – join us as we strengthen our research program. Apply now.

Apply Now

Infectious diseases remain an ongoing threat to global health security, despite decades of advances in hygiene, immunisation and antimicrobial therapies. Human population growth and mobility, political instability and climate change have increased the risk of new infectious diseases. Some previously controlled diseases have re-emerged as a result of declining effectiveness of vaccine programs, and increasing prevalence of drug-resistant strains. Maintenance of an “arsenal” of effective antibiotics by constraining the emergence and spread of antimicrobial resistant organisms is an urgent global priority.

The University of Melbourne and its partners in the Melbourne Biomedical Precinct and beyond are at the forefront of national and international efforts to limit the transmission and burden of infectious diseases.  We are achieving this through generation and synthesis of new knowledge across discovery, clinical, laboratory and public health domains, including leadership of the National Health and Medical Research Council (NHMRC), hosting the Commonwealth High Security Laboratories for work on level 3 and 4 pathogens within the Doherty Institute and the Australian Partnership for Preparedness Research on Infectious Disease Emergencies (APPRISE) and the One Health National Centre for Antimicrobial Stewardship (NCAS).  Our work impacts both policy and practice through engagement with State and Commonwealth Departments of Health, and involvement in key practitioner and advisory groups and networks.

The University of Melbourne is seeking new researchers at academic level C who can join in and benefit from our developing critical mass of research talent and facilities for infectious disease and antimicrobial resistance. We are seeking researchers with demonstrated expertise to build an internationally competitive research program in:

  • basic and translational virology in emerging viral infections
  • rapid diagnostics for emerging/resistant organisms
  • antimicrobial drug discovery and development
  • genomics, bioinformatics and metagenomics
  • mechanisms and pathogenesis of antimicrobial resistance
  • health informatics, in particular linkage and analysis of electronic record systems
  • implementation science and health services research
  • risk assessment and decision support.

Applications are open until 24th July 2018 and will require a:

For enquiries please email: mdhs-campaign@unimelb.edu.au

Apply Now

Key Partners, Schools and Centres at the University of Melbourne involved in disease prevention research:

Melbourne Medical School

School of Biomedical Sciences

Melbourne School of Population and Global Health

Faculty of Veterinary and Agricultural Sciences

Centre for Systems Biology

School of Biosciences

School of Mathematics and Statistics

School of Computing and Information Systems

Melbourne School of Psychological Sciences

School of Social and Political Sciences

Melbourne Academic Centre for Health (MACH)

The Royal Melbourne Hospital

The Royal Children's Hospital

The Royal Women's Hospital

The Peter MacCallum Cancer Centre

The Victorian Comprehensive Cancer Centre

The Walter and Eliza Hall Institute

The Murdoch Children’s Research Institute

Commonwealth Scientific and Industrial Research Organisation (CSIRO)

CSL

Bio21 Molecular Science & Biotechnology Institute

The Peter Doherty Institute for Infection and Immunity